Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Medtronic PLC (NYSE: MDT ) Dividend Yield: 3.22% UBS analyst Priya Sachdeva upgraded the stock from Neutral to Buy and raised the price target from $85 to $100 on July 28, 2026. This analyst has an accuracy rate of 61%. TD Cowen analyst Joshua Jennings maintained a Buy rating and cut the price target from $119 to $100 on July 10, 2026. This analyst has an accurac...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page.
Traders can sort through extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
Medtronic PLC (NYSE: MDT ) Dividend Yield: 3.22% UBS analyst Priya Sachdeva upgraded the stock from Neutral to Buy and raised the price target from $85 to $100 on July 28, 2026.
This analyst has an accuracy rate of 61%.
TD Cowen analyst Joshua Jennings maintained a Buy rating and cut the price target from $119 to $100 on July 10, 2026.
This analyst has an accuracy rate of 56%.
Recent News: On Aug.
6, Medtronic announced expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 Catheter for treatment of ventricular arrhythmias.
Pro’s real-time newsfeed alerted to latest MDT news.
GSK plc (NYSE: GSK ) Dividend Yield: 3.48% Barclays analyst James Gordon downgraded the stock from Equal-Weight to Underweight on Jan.
6, 2026.
This analyst has an accuracy rate of 67%.
Jefferies analyst Michael Leuchten upgraded the stock from Hold to Buy on Oct.
27, 2025.
This analyst has an accuracy rate of 59%.
Recent News: On July 28, GSK reported better-than-expected second-quarter financial results and issued FY31 sales guidance above estimates.
Pro’s real-time newsfeed alerted to latest GSK news Bristol-Myers Squibb Co (NYSE: BMY ) Dividend Yield: 3.89% Argus Research analyst Jasper Hellweg upgraded the stock from Hold to Buy with a price target of $75 on Aug.
5, 2026.
This analyst has an accuracy rate of 55%.
Citigroup analyst Geoff Meacham maintained a Neutral rating and raised the price target from $66 to $70 on Aug.
3, 2026.
This analyst has an accuracy rate of 74% Recent News: On Aug.
10, Bristol Myers Squibb announced plans to invest $2.3 billion in Houston manufacturing campus, creating nearly 500 jobs.
Pro’s real-time newsfeed alerted to latest BMY news Photo via Shutterstock